Calithera Biosciences Inc. (CALA)

Trade CALA now with
10/3/2022 7:39:54 AM Calithera Gets FDA Fast Track Designation For Sapanisertib For NRF2-mutated Squamous Lung Cancer
11/1/2021 7:15:36 AM Calithera Presents Interim Data From Phase 1b Trial Of Arginase Inhibitor CB-280 In Cystic Fibrosis
1/4/2021 7:13:06 AM Calithera: CANTATA Study Of Telaglenastat In Renal Cell Carcinoma Did Not Achieve Primary Endpoint
10/5/2017 7:37:55 AM William Blair Initiates Calithera Biosciences Inc. (CALA) At Outperform
1/24/2017 10:01:12 AM Citigroup Ups Calithera Biosciences Inc. (CALA) To neutral From sell With -- Price Target